selection_bias: rare-ranking-20261009-protocol-yuan2022-ddd-singleton-default
Descriptive fact transcribed from the pinned source.
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
6 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
| attributes.field selection_bias Context-only references | Evaluation of phenotype-driven gene prioritization methods for Mendelian diseases Discussions paragraph 3 Version: Briefings in Bioinformatics 23(2):bbac019, published 2022-02-04; PMC8921623 full-text XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| attributes.source_locator Discussions paragraph 3 Context-only references | Evaluation of phenotype-driven gene prioritization methods for Mendelian diseases Discussions paragraph 3 Version: Briefings in Bioinformatics 23(2):bbac019, published 2022-02-04; PMC8921623 full-text XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| attributes.value AMELIE tends to have an upper hand in identifying targets for published cases (DDD dataset); after removing 156 HGMD (Pro-2021.2) included cases, the remaining 149 unpublished DDD cases showed an almost-unchanged overall trend, with slightly lower AMELIE performance in the top-20 experiment. The subset results are shown only in Supplementary Figure 2. Context-only references | Evaluation of phenotype-driven gene prioritization methods for Mendelian diseases Discussions paragraph 3 Version: Briefings in Bioinformatics 23(2):bbac019, published 2022-02-04; PMC8921623 full-text XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| description Descriptive fact transcribed from the pinned source. Context-only references | Evaluation of phenotype-driven gene prioritization methods for Mendelian diseases Discussions paragraph 3 Version: Briefings in Bioinformatics 23(2):bbac019, published 2022-02-04; PMC8921623 full-text XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Relationship: subject rare-ranking-20261009-protocol-yuan2022-ddd-singleton-default Context-only references | Evaluation of phenotype-driven gene prioritization methods for Mendelian diseases Discussions paragraph 3 Version: Briefings in Bioinformatics 23(2):bbac019, published 2022-02-04; PMC8921623 full-text XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| name selection_bias: rare-ranking-20261009-protocol-yuan2022-ddd-singleton-default Context-only references | Evaluation of phenotype-driven gene prioritization methods for Mendelian diseases Discussions paragraph 3 Version: Briefings in Bioinformatics 23(2):bbac019, published 2022-02-04; PMC8921623 full-text XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Sources and history
Release 2026-10-10-6e93f504adfc · Record review: source checked
1 source records and release history
- Evaluation of phenotype-driven gene prioritization methods for Mendelian diseases · Original source · Briefings in Bioinformatics 23(2):bbac019, published 2022-02-04; PMC8921623 full-text XML
Technical metadata and extraction receipts
Stable ID: rare-ranking-20261009-claim-yuan2022-amelie-published-cases
- field
- selection_bias
- value
- AMELIE tends to have an upper hand in identifying targets for published cases (DDD dataset); after removing 156 HGMD (Pro-2021.2) included cases, the remaining 149 unpublished DDD cases showed an almost-unchanged overall trend, with slightly lower AMELIE performance in the top-20 experiment. The subset results are shown only in Supplementary Figure 2.
- source locator
- Discussions paragraph 3
- review
- method: source-hash-verification; ai-assisted-source-review; method note: Re-downloaded the article XML and matched its SHA-256, extracted the cited paragraphs with a separate parser and compared the claim text with them.; reviewer: claude; reviewer note: Separate Claude review agent, independent of the extractor; no human review claimed; date: 2026-10-09; artifact sha256: a0e15e5a113ecbc1c8a3b17072a4028c55ae53c09ba0677d6fdb7601cfc8f1ca; retrieval url: https://www.ebi.ac.uk/europepmc/webservices/rest/PMC8921623/fullTextXML; note: Hand transcription from the article text. Independent review 2026-10-09: Locator corrected from Discussion paragraph 1 to Discussions paragraph 3; the top-20 detail and the Supplementary Figure 2 locator were added.